AI-assisted source summary. Read the scope and exceptions, then follow the original documents below.
Applies to
United States · FDA and CDC 2024 investigation
Time context
2024 events; CDC investigation marked closed in December 2024
Sources checked
This is a historical safety case, not a new outbreak alert or a claim that every discounted injection is counterfeit. It does not provide treatment advice.
Two checks, not one
FDA warned of counterfeit Botox associated with adverse events, including hospitalizations. CDC's later update covered unsafe counterfeit products or injections by people not following local requirements. Product authenticity and the injector's qualifications are separate questions.
CDC recommends receiving injections only from licensed, trained providers using products obtained through authorized suppliers. Ask the provider to identify the product and its source. Packaging photos alone should not replace professional verification.
FDA advises people with concerning symptoms after botulinum toxin injections to contact a health professional or emergency care. Trouble breathing or swallowing needs immediate medical attention. Keep the product and provider details available for clinicians; do not wait for a seller's refund response.
Original documents used for this summary. Multiple links from one publisher are not independent corroboration. Policies can change after the check date.
AI-assisted research, writing and translation by No Secrets, using the linked public documents. This is a source summary, not firsthand reporting or an independently audited investigation. No affiliate links are used in this article.
The date above records this research pass, not the date of every underlying event. The English and Chinese versions are AI-assisted summaries; the linked original controls if they differ.